Q3 2021 Mirum Pharmaceuticals Inc Earnings Call Transcript
Hello, everyone, and welcome to the Mirum Pharmaceuticals Third Quarter Business Update Conference Call. My name is Victoria, and I'll be coordinating your call today. (Operator Instructions).
I will now hand over to your host, Ian Clements, Chief Financial Officer. Ian, please go ahead.
Thank you, Joy, and good afternoon, everyone. I'd like to welcome you to Mirum Pharmaceuticals Third Quarter 2021 Conference Call. I'm joined today by our President and CEO, Chris Peetz; Pam vig, Head of Research and Development; and Peter Radovich, Chief Operating Officer.
Earlier this afternoon, Mirum issued a news release announcing the company's results for the quarter ended September 30, 2021. Copies of this news release and SEC filings can be found in the Investors section of our website. Before we begin, I'd like to remind you that during the course of this conference call, we will be making certain forward-looking statements about Mirum and our progress -- and our programs based on management's current
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |